policy

Politics By Rachel Cohrs

Vulnerable Senate Democrats escalate a push for Medicare to negotiate drug prices

Health By Lev Facher

For the first time ever, Lander’s White House science office will have an entire wing dedicated to health

Politics By Rachel Cohrs

Senate Democrats eye drug pricing policies to fund $3.5 trillion budget deal

D.C. Diagnosis By Nicholas Florko

Are pharma mergers bad for biotech?

Politics By Rachel Cohrs

Washington’s antitrust push could limit Amazon, Google’s health care ambitions

Biotech By Damian Garde and Nicholas Florko

Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug

First Opinion By Sevahn Vorperian and Stephen Quake

The PASTEUR Act can help win the war against superbugs

Politics By Nicholas Florko

Powerful Democrat’s new drug pricing manifesto hints at a carveout for small biotechs

D.C. Diagnosis By Rachel Cohrs

The lonely quest to create a commission to investigate Covid-19

Politics By Rachel Cohrs

Biogen isn’t the only drug company that will profit from the new Alzheimer’s drug Aduhelm

Politics By Nicholas Florko

BIO’s chief on the FDA commissioner rumors, drug pricing, and IP rights 

Politics By Rachel Cohrs

Buying the data: Health care lobbyists fund their own policy analyses, clouding Washington debates

Business By Andrew Joseph

Member of FDA’s expert panel resigns over controversial Alzheimer’s therapy approval

First Opinion By David Blumenthal

Restore a better balance to public-private funding of biomedical research

Politics By Megan Molteni

California could become first state to mandate biosecurity screening by mail-order DNA companies

First Opinion By Parsa Erfani, Lawrence O. Gostin and Vanessa Kerry

Beyond a symbolic gesture: What’s needed to turn the IP waiver into Covid-19 vaccines

First Opinion By Jonathan Doh

Make drug companies partners — not adversaries — to expand global Covid-19 vaccine access

Opinions+ By John Freedman

The many benefits of expanding the reach of state all-payer claims databases

Health Tech By Andrew Joseph

Former Google CEO Schmidt says AI ‘will have its biggest impact’ in health care

Hospitals By Rachel Cohrs

HHS plans to open up billions in hospital Covid-19 grants in coming weeks

Politics By Rachel Cohrs

Top Senate Democrat heads back to drawing board on drug pricing

Politics By Lev Facher

Do public health officials need to be political activists? A fight over an HIV crisis renews the question

Health By Alicia Diaz

Door knocking works to get information to immigrant communities. Why aren’t more places using it for Covid-19?

Politics By Nicholas Florko and Rachel Cohrs

Worried drug pricing reform might be left behind, Democrat pushes Biden to make clear his support

First Opinion By Joe Lonsdale

FTC’s challenge to Illumina’s vertical merger with Grail is all wrong

Exclusive By Nicholas Florko

Biden officials met privately with 3M, AmerisourceBergen, PhRMA, and more to debate shoring up the national stockpile 

Opinions+ By Patrick McLaughlin and Tyler Richards

The FDA should embrace remote and automated drug inspection technology

Politics By Rachel Cohrs

The lobbying juggernaut the American Hospital Association is losing its top advocate at a critical moment for the industry

Politics By Nicholas Florko

Hints emerge about a key Senate committee’s plans for health care